Motus GI Holdings – Consensus Indicates Potential 157.7% Upside

Broker Ratings

Motus GI Holdings with ticker code (MOTS) have now 6 analysts covering the stock with the consensus suggesting a rating of ‘Strong_Buy’. The range between the high target price and low target price is between 3 and 2 calculating the mean target price we have 2.5. Now with the previous closing price of 0.97 this is indicating there is a potential upside of 157.7%. The 50 day moving average now sits at 0.9 and the 200 moving average now moves to 1.05. The market capitalisation for the company is $32m. You can visit the company’s website by visiting:

Motus GI Holdings, a medical technology company, provides endoscopy solutions that enhance clinical outcomes and the cost-efficiency associated with the diagnosis and management of gastrointestinal conditions in the United States and Israel. Its flagship product is the Pure-Vu system, a medical device to facilitate the cleaning of a poorly prepared colon during the colonoscopy procedure. The company is based in Fort Lauderdale, Florida.

You can now share this on Stocktwits, just click the logo below and add the ticker in the text to be seen.

Share on Stocktwits

Good news travels fast (but only if you make that happen). Share on:

Share on twitter
Share on linkedin
Share on facebook
Share on email
Share on reddit

AIM All Share Index